SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19

Anti-spike antibody testing has emerged as a powerful tool to assess SARS-CoV-2 vaccine response in solid organ transplant (SOT) recipients, many of whom remain at risk for COVID-19 despite vaccination. Neither the US Food and Drug Administration nor major transplant societies recommend testing anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Werbel, William A., Segev, Dorry L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2022
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111420/
https://www.ncbi.nlm.nih.gov/pubmed/35119179
http://dx.doi.org/10.1111/ajt.16993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111420/
https://www.ncbi.nlm.nih.gov/pubmed/35119179
http://dx.doi.org/10.1111/ajt.16993

Ejemplares similares